The document provides an overview of IVI, a company specializing in reproductive medicine. IVI was founded in 1990 in Valencia, Spain by Dr. Pellicer and Dr. Remohí. It has since expanded to over 27 medical centers across 7 countries. IVI aims to provide the highest quality reproductive care, conduct research, and train medical professionals internationally. It has over 1,200 employees and has helped create over 90,000 births through assisted reproduction treatments.

1. 17/Noviembre/2011
CORPORATE
PRESENTATION

2. 1. IVI PROJECT:
ORIGIN AND CURRENT SITUATION
PAG. 03
THE BEGINNING
• IVI came into being in 1990 thanks to the efforts of Doctor Pellicer and Doctor Remohí.
• Creation of the first clinic in Valencia, exclusively dedicated to Assisted Reproductive
Medicine.
• Accepting the challenge for specialization and team work in an emerging area of
medicine.

3. 1. IVI PROJECT:
ORIGIN AND CURRENT SITUATION
PAG. 04
• PATIENT SATISFACTION: EXEMPLARY CARE FOR PATIENTS WITH THE BEST
POSSIBLE RESULTS.
• AN INTEGRATED TEAM AND A “SCHOOL” IN THE AREA OF ASSISTED
REPRODUCTION
• SCIENTIFIC PRODUCTIVITY.
• STRONG TIES WITH THE UNIVERSITY AND THE ACADEMIC COMMUNITY.
IMPORTANT ELEMENTS OF THE PROJECT

4. 2.
PAG. 06
MISSION
We are a team of qualified professionals working
on a common project: carrying out reproductive
medicine of the highest order and fostering
research, education and professional excellence.
To be a world-leading team in the field of
reproductive medicine, becoming the most
widespread group with the best clinical results. To
be an international reference point in quality care,
research and teaching. Prioritizing the development
of people and team spirit as the pillars of our
project.
VISION
MISSION, VISION AND VALUES

5. 2.
PAG. 07
VALUES
... These make all of us proud to be part of IVI.
• FREEDOM OF INITIATIVE AND INNOVATION
• DESIRE FOR SELF-IMPROVEMENT
• SATISFACTION FOR A JOB WELL DONE
• TEAM WORK
• HONESTY
• LOYALTY
MISSION, VISION AND VALUES

6. PAG. 09
3.
• Clinics in 7 countries.
• 27 medical centers.
• 32,000 AR treatments in 2014.
• More than 90,000 births until now.
• Approx. 24% of the patients come from countries where
we do not have any centers.
• Patients from more than 85 countries (historically 106).
Leader in Reproductive Medicine
BASIC FACTS ABOUT THE COMPANY

7. PAG. 11
3.
IVI Group has more than 1,200 employees on its staff, 83% are women.
IVI Group´s employees
BASIC FACTS ABOUT THE COMPANY

8. PAG. 13
Valencia (2)
Castellón
Murcia
Cartagena
Madrid (2)
Almería
Sevilla
Barcelona
Vigo
Alicante
Elche
Bilbao
Santander
Las Palmas
Zaragoza
Málaga (2)
San Sebastián
México
Lisbon
Santiago de Chile
Panamá
Buenos Aires
Salvador de Bahía
Sao Paulo
4. WORLDWIDE PRESENCE:
IVI CENTERS

9. 4.
PAG. 17
BARCELONA
Head Doctor:
Dr. Agustín Ballesteros
IVI CLINICS IN THE WORLD:
WORLDWIDE PRESENCE:
IVI CENTERS

10. 6.
Research, Education and Social Activity
Development in any area of medicine, and especially in Reproductive Medicine, currently
requires basic research upon which to base its growth and evolution, and needs to be
socially projected in order to inform people who may benefit from these treatments.
FUNDACIÓN IVI was created
as a non-profit organization
in 1997 and since then it has
been widening its scope of
work to develop the three
main pillars that today make
up its backbone:
Investigation, Teaching and
Social Action
PAG. 40
FUNDACIÓN IVI:
A FOUNDATION FULL OF LIFE

11. 6.
Research and development
Headed by Prof. Dr. Carlos Simón
A multidisciplinary team of doctors,
biologist, chemists, pharmacologists,
biochemists, etc.
Basic and applied research
Private laboratories
Cooperation with Universities in
Spain and abroad.
PAG. 41
FUNDACIÓN IVI:
A FOUNDATION FULL OF LIFE

12. 6.
Research and development – Main activity lines:
• Viability of new means of embryo culture
• Ovarian Hyperstimulation Syndrome (OHSS)
• Endometriosis
• Embryo Implantation: HLA-G gene polymorphism/cell recycling
• Genetics/Preimplantational Genetic Diagnosis (PGD)
• Embryo quality indicators
• Spermatozoa fertility Indicators
• Cryopreservation of oocytes and ovarian tissue
• Optimization program for ovum donations
• Stem cell lines
PAG. 42
FUNDACIÓN IVI:
A FOUNDATION FULL OF LIFE

13. 7.
PAG. 46
ACTIVITY AREAS
Reproduction:
Human Sterility
Andrology
Genetics
Endoscopic surgery
ART Laboratories:
Insemination
IVF/ICSI
PGD
Cryopreservation
Endocrinology
Inmunology
Central services:
Analysis
Genetics
Obstetrics/Pediatrics:
MFMU: Morphological sonography,
High-risk pregnancies
Pediatrics
Women’s health
Men’s health
Psychology

14. 8.
39 AWARDS AND PRIZES
PAG. 48
AWARDS AND PRIZES
• 8 American Society for Reproductive Medicine (ASRM) awards
• 4 Health 2000
• 12 SEF (Sociedad Española de la Fertilidad)
• 4 SEGO (Sociedad Española de Ginecología y Obstetricia)
• Jaume I award for Clinical Medicine (Prof. Pellicer and Prof. Simón)
• NOVA award (Best Company in Biomedicine Sector) of the C.V
• Gold Medal award of Valencia for Research and Teaching
• “Best Place to Work” – Spain 2008, 2009 y 2010
• “Empresa Revelación de la Comunidad Valenciana” award by the magazine Actualidad
Económica
• “Valencianos Siglo XXI” award of Las Provincias
• 2 ASA (American Society of Andrology)
• Innovation award 2012 (Ernst & Young Entrepreneur Of The Year 2012)
• Jacques Salat-Baroux 2014 award to Prof. Antonio Pellicer from the French National Academy
of Medicine.

15. 9.
PAG. 50
OTHER BUSINESS UNITS:
Web: www.ivi-co.com

16. 9.
PAG. 50
OTHER BUSINESS UNITS:
IGENOMIX
iGenomix, is the company of the IVI Group whose objective is to create and
develop diagnostic specific tools to support professionals in the reproductive
medicine field.
IGenomix, is the company with the most preimplantation genetic diagnosis
(PGD) cycles performed in Europe and one of the world references in this type
of techniques. IGenomix has its own laboratories outside Spain for meeting the
increasing demand for international services, specifically in Delhi (India), Sao
Paulo (Brazil) and Dubai. It also has a subsidiary in the US (IVIGEN) with an
important presence in the North-American market and laboratories in Miami
and Los Angeles as well as with a local associate in Milan (Italy).
PAG. 51

17. 9.
PAG. 50
OTHER BUSINESS UNITS:
IGENOMIX
PAG. 51

18. 9.
PAG. 52
OTHER BUSINESS UNITS:
IVIDA
IVIDA collects, processes, cryopreserves and stores the stem cells of
the Umbilical Cord Blood (UCB) for the treatment of different
diseases such as lymphomas, leukemias, or anemias. With the
guarantee that it will be managed completely by employees of the
company (in our own facilities), therefore assuring the traceability
and complete control of the whole process.
Cord Blood Bank of the IVI group